MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
🇺🇸United States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

Phase 2
Active, not recruiting
Conditions
Granulosa Cell Ovarian Cancer
Low Grade Serous Ovarian/ Primary Peritoneal Cancer
Endometrioid Endometrial Cancer
Interventions
First Posted Date
2019-04-09
Last Posted Date
2024-05-02
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
34
Registration Number
NCT03909152
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States

🇺🇸

Memorial Sloan Kettering Nassau, Uniondale, New York, United States

and more 5 locations

Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer

Not Applicable
Terminated
Conditions
Cancer
Interventions
Other: automated geriatric co-management
Other: in-person geriatric co-management
First Posted Date
2019-03-22
Last Posted Date
2024-03-25
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
20
Registration Number
NCT03885908
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer

Phase 1
Terminated
Conditions
Small Cell Lung Cancer
Interventions
Drug: DS-3201b
Drug: irinotecan
First Posted Date
2019-03-19
Last Posted Date
2024-10-10
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
22
Registration Number
NCT03879798
Locations
🇺🇸

Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Nassau, Uniondale, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Commack, Commack, New York, United States

and more 4 locations

Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer

Phase 2
Withdrawn
Conditions
Colorectal Cancer
Interventions
First Posted Date
2019-03-19
Last Posted Date
2019-12-12
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Registration Number
NCT03879811

Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

Withdrawn
Conditions
Non Small Cell Lung Cancer
Interventions
Diagnostic Test: Pre-Treatment Biopsy
Diagnostic Test: On-Treatment Biopsy
Diagnostic Test: Biopsy at Disease Progression
Diagnostic Test: Peripheral Blood-Based Studies
First Posted Date
2019-03-15
Last Posted Date
2020-08-31
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Registration Number
NCT03877250
Locations
🇺🇸

Memoral Sloan Kettering Monmouth (Consent and Follow up), Middletown, New Jersey, United States

🇺🇸

Memoral Sloan Kettering Basking Ridge (Consent and Follow up), Basking Ridge, New Jersey, United States

🇺🇸

Memoral Sloan Kettering Westchester (Consent & Follow Up), Harrison, New York, United States

and more 3 locations

A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma

Phase 1
Completed
Conditions
Mantle Cell Lymphoma (MCL)
Interventions
First Posted Date
2019-03-15
Last Posted Date
2022-12-14
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
8
Registration Number
NCT03877055
Locations
🇺🇸

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Commack, Commack, New York, United States

and more 3 locations

Determining Whether Intra-Arterial Carboplatin Causes Hearing Loss in Children

Completed
Conditions
Hearing Loss
Intraocular Retinoblastoma
Interventions
Diagnostic Test: Distortion product otoacoustic emission measurement (DPOAE)
First Posted Date
2019-03-07
Last Posted Date
2024-11-07
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
30
Registration Number
NCT03866460
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients

Not Applicable
Active, not recruiting
Conditions
Cancer Caregivers
Interventions
Behavioral: Baseline questionnaire
Behavioral: NCCN Problem List
Behavioral: FACT-GP
Behavioral: HADS
Behavioral: CSS-CG
First Posted Date
2019-02-27
Last Posted Date
2024-08-14
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
150
Registration Number
NCT03856086
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Consumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos)

Phase 2
Conditions
Obesity
Overweight
Interventions
Behavioral: Initial in-person individual diet and exercise counseling (N vs. Y)
Behavioral: Thrice weekly diet and exercise text messages (N vs. Y)
Behavioral: Weekly telephone support (N vs. Y)
Behavioral: Self-monitoring tools (N vs. Y) (for diet and weight)
First Posted Date
2019-02-22
Last Posted Date
2024-06-21
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
1067
Registration Number
NCT03851458
Locations
🇺🇸

Mexican Consulate's Ventanilla de Salud (VDS), New York, New York, United States

A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers

Phase 1
Completed
Conditions
Advanced BRAF Mutant Cancers
Interventions
First Posted Date
2019-02-18
Last Posted Date
2024-10-21
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
17
Registration Number
NCT03843775
Locations
🇺🇸

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

🇺🇸

Memorial Sloan Kettering Cancer Center @ Suffolk (Limited protocol activity), Commack, New York, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath